• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

通过上调人1型血管活性肠肽受体抑制神经母细胞瘤细胞的致瘤性。

Suppression of tumorigenicity in neuroblastoma cells by upregulation of human vasoactive intestinal peptide receptor type 1.

作者信息

Balster Douglas A, O'Dorisio M Sue, Albers Anne R, Park Sang K, Qualman Stephen J

机构信息

Department of Pathology, The Ohio State University, Columbus, OH 43205, USA.

出版信息

Regul Pept. 2002 Nov 15;109(1-3):155-65. doi: 10.1016/s0167-0115(02)00199-4.

DOI:10.1016/s0167-0115(02)00199-4
PMID:12409228
Abstract

We hypothesize that vasoactive intestinal peptide (VIP) promotes neural crest differentiation through VIP receptor type I (VPAC1). In order to test this hypothesis, SKNSH neuroblastoma cells were stably transfected with VPAC1 and receptor expression was verified by real-time RT-PCR. Overexpression of VPAC1 in SKNSH cells resulted in upregulation of endogenous retinoic acid receptor expression for both RARalpha and RXRalpha with no change in expression of RARbeta. Transfected cells demonstrated high affinity binding of VIP (K(D)=0.2 nM) and VIP-mediated stimulation of adenylate cyclase and a shift in cell cycle kinetics to a near triploid DNA index in G1. SKNSH/VPAC1 cells treated with VIP were observed to express a more differentiated phenotype compared to wild type cells as characterized by an increase in tissue transglutaminase II and a decrease in bcl-2 immunostaining. VIP-induced differentiation effects were potentiated by retinoic acid. This differentiation resulted in decreased proliferative potential in a xenograft model. Whereas, wild type SKNSH cells induced tumor growth in 100% of nude mice within 13 days post-injection, SKNSH transfected with VPAC1 demonstrated no tumor formation in xenografts followed for 6 months. Taken together, these data support the hypothesis that VIP modulation of neural crest differentiation is mediated via VPAC1 and that high expression of VPAC1 induces differentiation in and decreases tumorigenicity of neuroblastoma cells.

摘要

我们推测血管活性肠肽(VIP)通过I型VIP受体(VPAC1)促进神经嵴分化。为了验证这一推测,我们用VPAC1稳定转染了SKNSH神经母细胞瘤细胞,并通过实时RT-PCR验证了受体表达。SKNSH细胞中VPAC1的过表达导致内源性视黄酸受体RARα和RXRα的表达上调,而RARβ的表达没有变化。转染细胞表现出对VIP的高亲和力结合(K(D)=0.2 nM)以及VIP介导的腺苷酸环化酶刺激,并且细胞周期动力学发生改变,在G1期的DNA指数接近三倍体。与野生型细胞相比,用VIP处理的SKNSH/VPAC1细胞表现出更分化的表型,其特征是组织转谷氨酰胺酶II增加,bcl-2免疫染色减少。视黄酸增强了VIP诱导的分化作用。这种分化导致异种移植模型中的增殖潜力降低。野生型SKNSH细胞在注射后13天内可使100%的裸鼠发生肿瘤生长,而转染VPAC1的SKNSH细胞在长达6个月的异种移植中未形成肿瘤。综上所述,这些数据支持以下推测:VIP对神经嵴分化的调节是通过VPAC1介导的,并且VPAC1的高表达可诱导神经母细胞瘤细胞分化并降低其致瘤性。

相似文献

1
Suppression of tumorigenicity in neuroblastoma cells by upregulation of human vasoactive intestinal peptide receptor type 1.通过上调人1型血管活性肠肽受体抑制神经母细胞瘤细胞的致瘤性。
Regul Pept. 2002 Nov 15;109(1-3):155-65. doi: 10.1016/s0167-0115(02)00199-4.
2
Retinoic acid regulation of the VIP and PACAP autocrine ligand and receptor system in human neuroblastoma cell lines.维甲酸对人神经母细胞瘤细胞系中血管活性肠肽(VIP)和垂体腺苷酸环化酶激活肽(PACAP)自分泌配体及受体系统的调节
Peptides. 1997;18(6):835-41. doi: 10.1016/s0196-9781(97)00015-6.
3
Vasoactive intestinal peptide: autocrine growth factor in neuroblastoma.
Regul Pept. 1992 Feb 18;37(3):213-26. doi: 10.1016/0167-0115(92)90616-3.
4
A cloned frog vasoactive intestinal polypeptide/pituitary adenylate cyclase-activating polypeptide receptor exhibits pharmacological and tissue distribution characteristics of both VPAC1 and VPAC2 receptors in mammals.克隆的蛙血管活性肠肽/垂体腺苷酸环化酶激活肽受体具有哺乳动物中VPAC1和VPAC2受体的药理学及组织分布特征。
Endocrinology. 1999 Mar;140(3):1285-93. doi: 10.1210/endo.140.3.6576.
5
VPAC2-R mediates the lipolytic effects of pituitary adenylate cyclase-activating polypeptide/vasoactive intestinal polypeptide in primary rat adipocytes.VPAC2受体介导垂体腺苷酸环化酶激活肽/血管活性肠肽对原代大鼠脂肪细胞的脂解作用。
Endocrinology. 2005 Feb;146(2):744-50. doi: 10.1210/en.2004-0504. Epub 2004 Oct 28.
6
Expression localisation and functional activity of pituitary adenylate cyclase-activating polypeptide, vasoactive intestinal polypeptide and their receptors in mouse ovary.垂体腺苷酸环化酶激活多肽、血管活性肠肽及其受体在小鼠卵巢中的表达定位与功能活性
Reproduction. 2007 Aug;134(2):281-92. doi: 10.1530/REP-07-0051.
7
Regulation of vasoactive intestinal peptide receptor expression in developing nervous systems.
Ann N Y Acad Sci. 2000;921:165-74. doi: 10.1111/j.1749-6632.2000.tb06963.x.
8
VIP receptor 1 (VPAC1) promoter targets the expression of a reporter gene to cerebellum and adrenal medulla in transgenic mice.
Regul Pept. 2003 Nov 15;116(1-3):1-12. doi: 10.1016/s0167-0115(03)00170-8.
9
Serine 447 in the carboxyl tail of human VPAC1 receptor is crucial for agonist-induced desensitization but not internalization of the receptor.人VPAC1受体羧基末端的丝氨酸447对激动剂诱导的脱敏至关重要,但对受体的内化并不重要。
Mol Pharmacol. 2003 Dec;64(6):1565-74. doi: 10.1124/mol.64.6.1565.
10
Human H9 cells proliferation is differently controlled by vasoactive intestinal peptide or peptide histidine methionine: implication of a GTP-insensitive form of VPAC1 receptor.血管活性肠肽或肽组氨酸甲硫氨酸对人H9细胞增殖的调控存在差异:一种对GTP不敏感的VPAC1受体的影响
J Neuroimmunol. 2005 Jan;158(1-2):94-105. doi: 10.1016/j.jneuroim.2004.08.018.

引用本文的文献

1
[VIPR1 promoter methylation promotes transcription factor AP-2 binding to inhibit VIPR1 expression and promote hepatocellular carcinoma cell growth ].血管活性肠肽受体1(VIPR1)启动子甲基化促进转录因子AP-2结合,抑制VIPR1表达并促进肝癌细胞生长
Nan Fang Yi Ke Da Xue Xue Bao. 2022 Jul 20;42(7):957-965. doi: 10.12122/j.issn.1673-4254.2022.07.01.
2
Epigenetic control of cancer by neuropeptides.神经肽对癌症的表观遗传调控。
Biomed Rep. 2017 Jan;6(1):3-7. doi: 10.3892/br.2016.804. Epub 2016 Nov 8.
3
Neuropeptides of the VIP family inhibit glioblastoma cell invasion.
血管活性肠肽(VIP)家族的神经肽可抑制胶质母细胞瘤细胞的侵袭。
J Neurooncol. 2015 Mar;122(1):63-73. doi: 10.1007/s11060-014-1697-6. Epub 2015 Jan 7.
4
Vasoactive intestinal peptide signaling axis in human leukemia.人类白血病中的血管活性肠肽信号轴
World J Biol Chem. 2011 Jun 26;2(6):146-60. doi: 10.4331/wjbc.v2.i6.146.
5
2-deoxy-D-glucose induces oxidative stress and cell killing in human neuroblastoma cells.2-脱氧-D-葡萄糖诱导人神经母细胞瘤细胞氧化应激和细胞死亡。
Cancer Biol Ther. 2010 Jun 1;9(11):853-61. doi: 10.4161/cbt.9.11.11632. Epub 2010 Jun 26.
6
The role of vasoactive intestinal peptide (VIP) in megakaryocyte proliferation.血管活性肠肽(VIP)在巨核细胞增殖中的作用。
J Mol Neurosci. 2009 Feb;37(2):160-7. doi: 10.1007/s12031-008-9119-x. Epub 2008 Jul 29.
7
Role of gastrointestinal hormones in neuroblastoma.胃肠激素在神经母细胞瘤中的作用。
World J Surg. 2005 Mar;29(3):281-6. doi: 10.1007/s00268-004-7815-4.